HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) EVP Delano Ladd sold 7,500 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the transaction, the executive vice president directly owned 91,141 shares of the company’s stock, valued at $8,202,690. The trade was a 7.60% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
HealthEquity Stock Performance
NASDAQ:HQY opened at $85.21 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The stock has a market capitalization of $7.12 billion, a P/E ratio of 31.91, a PEG ratio of 1.52 and a beta of 0.21. The company has a 50 day moving average price of $83.85 and a 200 day moving average price of $86.42. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $116.65.
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The firm had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities research analysts forecast that HealthEquity, Inc. will post 3.84 EPS for the current year.
Institutional Investors Weigh In On HealthEquity
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on the stock. UBS Group set a $110.00 price objective on shares of HealthEquity in a research report on Tuesday, February 17th. BTIG Research reduced their target price on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a report on Tuesday, February 17th. Royal Bank Of Canada increased their target price on shares of HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday. Jefferies Financial Group set a $108.00 target price on shares of HealthEquity in a report on Thursday, February 19th. Finally, KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $110.57.
View Our Latest Stock Analysis on HealthEquity
HealthEquity Company Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Recommended Stories
- Five stocks we like better than HealthEquity
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
